Evaluation of accuracy, exclusivity, limit-of-detection and ease-of-use of LumiraDx™: An antigen-detecting point-of-care device for SARS-CoV-2.
Krüger LJ, Klein JAF, Tobian F, Gaeddert M, Lainati F, Klemm S, Schnitzler P, Bartenschlager R, Cerikan B, Neufeldt CJ, Nikolai O, Lindner AK, Mockenhaupt FP, Seybold J, Jones TC, Corman VM, Pollock NR, Knorr B, Welker A, de Vos M, Sacks JA, Denkinger CM; ACE-IT Study Group.
Krüger LJ, et al.
Infection. 2022 Apr;50(2):395-406. doi: 10.1007/s15010-021-01681-y. Epub 2021 Aug 12.
Infection. 2022.
PMID: 34383260
Free PMC article.